Navigation Links
ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
Date:2/14/2011

CHICAGO, Feb. 14, 2011 /PRNewswire/ -- Zoledronic acid (sold by Novartis as Zometa, Aclasta, and Reclast) is used to treat Osteoporosis, Tumor Metastasis, and Paget's Disease with sales of $2 billion a year.(1)  It is associated with side effects such as post-dose syndrome and osteonecrosis of the jaw.  A new patented method from Dr. Ketan Desai enables the administration of Zoledronic acid in combination with another drug that relieves the side effects.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

This patented method will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Key Characteristics of MethodThe patents disclose the following:


  • Method enables administration of zoledronic acid in a novel combination.
  • Method results in decreased side effects.
  • Can be administered though different methods: oral supply, inhalation, muscle injection, or veindrip.
  • Market OverviewThese patents may be of interest in the following areas:


  • The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expect to reach $32.8 billion in 2013.(2)
  • These patents would be of interest to: pharmaceutical companies, drug manufacturers, healthcare service providers, and biomedical research.
  • To learn more about the assets available for sale in this portfolio: Contact Dean Becker of ICAP Ocean Tomo at Dean.Becker@us.icap.comAbout ICAP Ocean Tomo LLCICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.

    About IC
    '/>"/>

    SOURCE ICAP Ocean Tomo
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo
    2. ICAP Ocean Tomo to Auction 7 Exclusive Licenses from Lawrence Livermore National Laboratory at Fall Auction November 11th in Napa, California
    3. Skin Lesion Identification System to Auction on November 11th at ICAP Ocean Tomos Fall 2010 Live IP Auction
    4. ICAP Ocean Tomo Offers for Sale IP Portfolio of Active Implants for Electromagnetic Bone and Tissue Regeneration in Orthopedics, Trauma, and Wound Care
    5. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
    6. ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
    7. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
    8. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
    9. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
    10. Dynatronics Announces Fiscal Second Quarter Results
    11. K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with ... care management solutions powered by Qualcomm Life,s 2net™ ... to enable continuous care, informed interventions and better ... at Qualcomm Life,s annual Connect 2015 ...
    (Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 ... Co., Ltd., and Purdue Pharma L.P. announced today that ... the development and commercialization of Eisai,s clinical candidate lemborexant ... Phase III clinical development for the treatment of insomnia. ... Eisai and Purdue Pharma will share the costs of ...
    (Date:8/30/2015)... Switzerland , August 31, 2015 ... healthbank to deliver ... , the world,s first citizen-owned health data transaction platform, ... and Netcetera to engineer and bring to ...      (Logo: http://photos.prnewswire.com/prnh/20150828/261966) , "Our business model ...
    Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
    ... 31 Gen-Probe Incorporated,(Nasdaq: GPRO ) announced ... U.S.,clinical trial of its investigational APTIMA(R) assay to ... "Starting this highly complex, multi-center study was an ... Hull, the Company,s president and,chief operating officer. "Enrolling ...
    ... Three Key Lipids and Had ... CHICAGO, March 31 New data from ... multiple lipid problems, Abbott,s,ABT-335 combined with two commonly ... lipids -- LDL "bad",cholesterol, triglycerides and HDL "good" ...
    Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 2Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 3Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 4Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 5Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 2Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 3
    (Date:8/31/2015)... ... August 31, 2015 , ... Garden State ... 2008, the result of a merger of five of the busiest urology practices ... could provide more cost-effective and higher quality care than they did individually. ...
    (Date:8/31/2015)... ... ... Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as ... graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity ... his senior year. He was inducted into the National Honor Society as a sophomore, ...
    (Date:8/31/2015)... ... ... Dr. Stewart Shofner of Shofner Vision Center explains what causes ... comprehensive eye examination can diagnose amblyopia. According to the National Eye Institute ... 2 to 3 out of every 100 children. , Dr. Shofner adds, “unless ...
    (Date:8/31/2015)... Creek, CA (PRWEB) , ... August 31, 2015 ... ... national print and digital marketing communications company announced today that it has officially ... Fonzi, DP President, the new website and brand refresh are more closely aligned ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Three Bakers Gluten Free Bakery launched the redesign ... relevant and easy-to-find information on their offering of gluten-free breads and pizzas, living without ... important way for us to share information about our gluten free product offerings, but ...
    Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
    ... Global Breast ... Cancer Incidence, Mortality Rates, WASHINGTON, March 12 First ... for the Cure (R) Global Promise Fund at a,Capitol Hill ... its new strategy of funding culturally sensitive,sustainable education and outreach ...
    ... - Completed LogistiCare acquisition ... - Vanderbilt study released showing 81% success rate - Fourth ... and $6 million from social services ... segment, - Fourth quarter diluted earnings per share of $0.35, ...
    ... March 12 The following was,issued today by ... Forum (NQF) Implementation Conference on Care,Coordination and 2008 ... http://www.qualityforum.org ., March 26: Spring Membership ... NQF membership and leaders of the National Priorities,Partners, ...
    ... use ibuprofen for arthritis pain or other conditions while ... stroke undermine aspirins ability to act as an anti-platelet ... , In a cohort of patients seen by physicians ... patients were identified as taking both aspirin and ibuprofen ...
    ... Significantly Impact Patient Health and Financial ... Performance of Pharmaceutical Companies, NEW YORK and LONDON, ... billion per year and causing an,estimated 125,000 deaths per year ... the healthcare industry. Eularis has,responded to this problem with a ...
    ... finding shouldn,t keep physicians from using Avastin, researchers say , , ... drug Avastin can cause kidney damage by doing what it,s ... shows. , Avastin, whose generic name is bevacizumab, is the ... cancers by cutting off their blood supply. It does this ...
    Cached Medicine News:Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 2Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 2Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 4Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 5Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 6Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 7Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 8Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 9Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 10Health News:National Quality Forum Spring Conference; Leaders in Healthcare Quality to Focus on National Priorities and Care Coordination 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 3Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3
    For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
    ZyDoc offers a full medical transcription and documentation solution....
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    Medicine Products: